Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators

被引:384
作者
Bodenmiller, Bernd [1 ]
Zunder, Eli R. [1 ]
Finck, Rachel [1 ]
Chen, Tiffany J. [1 ,2 ,3 ]
Savig, Erica S. [1 ,4 ]
Bruggner, Robert V. [1 ,2 ]
Simonds, Erin F. [1 ]
Bendall, Sean C. [1 ]
Sachs, Karen [1 ]
Krutzik, Peter O. [1 ]
Nolan, Garry P. [1 ]
机构
[1] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA
[2] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA
[4] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA
基金
瑞士国家科学基金会;
关键词
KINASE INHIBITOR SELECTIVITY; POLYCHROMATIC FLOW-CYTOMETRY; FUNCTIONAL GENOMICS; DRUG DISCOVERY; IMMUNE-SYSTEM; CANCER; CELLS; PROTEOMICS; RESPONSES; POPULATIONS;
D O I
10.1038/nbt.2317
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mass cytometry facilitates high-dimensional, quantitative analysis of the effects of bioactive molecules on human samples at single-cell resolution, but instruments process only one sample at a time. Here we describe mass-tag cellular barcoding (MCB), which increases mass cytometry throughput by using n metal ion tags to multiplex up to 2(n) samples. We used seven tags to multiplex an entire 96-well plate, and applied MCB to characterize human peripheral blood mononuclear cell (PBMC) signaling dynamics and cell-to-cell communication, signaling variability between PBMCs from eight human donors, and the effects of 27 inhibitors on this system. For each inhibitor, we measured 14 phosphorylation sites in 14 PBMC types at 96 conditions, resulting in 18,816 quantified phosphorylation levels from each multiplexed sample. This high-dimensional, systems-level inquiry allowed analysis across cell-type and signaling space, reclassified inhibitors and revealed off-target effects. High-content, high-throughput screening with MCB should be useful for drug discovery, preclinical testing and mechanistic investigation of human disease.
引用
收藏
页码:858 / U89
页数:12
相关论文
共 50 条
  • [1] Toll-like receptor signalling
    Akira, S
    Takeda, K
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) : 499 - 511
  • [2] Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
    Anastassiadis, Theonie
    Deacon, Sean W.
    Devarajan, Karthik
    Ma, Haiching
    Peterson, Jeffrey R.
    [J]. NATURE BIOTECHNOLOGY, 2011, 29 (11) : 1039 - U117
  • [3] HUMAN INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR-ALPHA PRODUCTION STUDIED AT A SINGLE-CELL LEVEL
    ANDERSSON, U
    MATSUDA, T
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (06) : 1157 - 1160
  • [4] Network Systems Biology for Drug Discovery
    Arrell, D. K.
    Terzic, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) : 120 - 125
  • [5] Assessment of Chemical Coverage of Kinome Space and Its Implications for Kinase Drug Discovery
    Bamborough, Paul
    Drewry, David
    Harper, Gavin
    Smith, Gary K.
    Schneider, Klaus
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (24) : 7898 - 7914
  • [6] Mass Cytometry: Technique for Real Time Single Cell Multitarget Immunoassay Based on Inductively Coupled Plasma Time-of-Flight Mass Spectrometry
    Bandura, Dmitry R.
    Baranov, Vladimir I.
    Ornatsky, Olga I.
    Antonov, Alexei
    Kinach, Robert
    Lou, Xudong
    Pavlov, Serguei
    Vorobiev, Sergey
    Dick, John E.
    Tanner, Scott D.
    [J]. ANALYTICAL CHEMISTRY, 2009, 81 (16) : 6813 - 6822
  • [7] Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
    Bantscheff, Marcus
    Eberhard, Dirk
    Abraham, Yann
    Bastuck, Sonja
    Boesche, Markus
    Hobson, Scott
    Mathieson, Toby
    Perrin, Jessica
    Raida, Manfred
    Rau, Christina
    Reader, Valerie
    Sweetman, Gavain
    Bauer, Andreas
    Bouwmeester, Tewis
    Hopf, Carsten
    Kruse, Ulrich
    Neubauer, Gitte
    Ramsden, Nigel
    Rick, Jens
    Kuster, Bernhard
    Drewes, Gerard
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (09) : 1035 - 1044
  • [8] Revealing promiscuous drug-target interactions by chemical proteomics
    Bantscheff, Marcus
    Scholten, Arjen
    Heck, Albert J. R.
    [J]. DRUG DISCOVERY TODAY, 2009, 14 (21-22) : 1021 - 1029
  • [9] An investigation of liquid carryover and sample residual for a high-throughput flow cytometer sample delivery system
    Bartsch, JW
    Tran, HD
    Waller, A
    Mammoli, AA
    Buranda, T
    Sklar, LA
    Edwards, BS
    [J]. ANALYTICAL CHEMISTRY, 2004, 76 (13) : 3810 - 3817
  • [10] Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
    Bendall, Sean C.
    Simonds, Erin F.
    Qiu, Peng
    Amir, El-ad D.
    Krutzik, Peter O.
    Finck, Rachel
    Bruggner, Robert V.
    Melamed, Rachel
    Trejo, Angelica
    Ornatsky, Olga I.
    Balderas, Robert S.
    Plevritis, Sylvia K.
    Sachs, Karen
    Pe'er, Dana
    Tanner, Scott D.
    Nolan, Garry P.
    [J]. SCIENCE, 2011, 332 (6030) : 687 - 696